Latest News and Press Releases

BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home observational real-world evidence...

RESEARCH TRIANGLE PARK, NC--(Marketwired - May 30, 2017) - Approximately 78% of surveyed life science teams with dedicated post-marketing groups align them under medical affairs, according to new...

RESEARCH TRIANGLE PARK, NC--(Marketwired - April 27, 2017) - The majority (82%) of surveyed drug manufacturers reported conducting -- or planning to conduct -- observational studies last year, which...

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 15, 2017) - Global pharmaceutical businesses are the most likely to involve multiple functions in postmarketing, or Phase 4, study planning. A...

RESEARCH TRIANGLE PARK, NC--(Marketwired - November 29, 2016) - Medical affairs functions are an ideal candidate to head post-marketing study strategy, according to new research published by...

RESEARCH TRIANGLE PARK, NC--(Marketwired - August 31, 2016) - A new study published by Cutting Edge Information reported that 70% of surveyed pharmaceutical firms employ Phase 4 groups at the global...

CARY, NC--(Marketwired - July 19, 2016) - Industry Standard Research has released a new report, "Late Phase Study Trends and Market Outlook (2016-2020)," containing findings focused on current...

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 19, 2016) - A new study published by Cutting Edge Information found that at least one Top 10 pharmaceutical company grew its post-marketing study...

RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - A new study published by Cutting Edge Information discovered that 61% of interventional studies are traditional randomized control trials...